• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    MPO's 2023 Medical Device Industry Year in Review

    The Beat Goes On in the Cardiovascular Device Market

    Medical Manufacturers Gain Support from 3D Printing

    The Intelligent Tools Medical Device Manufacturers Already Own

    MPO's 2023 Medtech Supply Chain Survey
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    MPO's Most-Read Stories This Week—Dec. 9

    Babson Diagnostics’ BetterWay Achieves Regulatory Milestone

    WhiteSwell Successfully Treats Acute Decompensated Heart Failure in Study

    Everly Health Releases At-Home Collection Kidney Health Test

    Kenco Adds Two to its Life Sciences Division Team
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    MPO's 2023 Medical Device Industry Year in Review

    The Beat Goes On in the Cardiovascular Device Market

    Medical Manufacturers Gain Support from 3D Printing

    The Intelligent Tools Medical Device Manufacturers Already Own

    MPO's 2023 Medtech Supply Chain Survey
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    A Peek Into the 2028 MPO Summit

    Retail Healthcare Disruptors and Medical Devices

    Six Developments Your Talent Strategy Should Prepare for in 2024

    The Power and Paradox of Never

    Navigating the Q-Sub Program: How Experienced Lab Partners Can Help Streamline Regulatory Submission
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Poly-Med, Inc.

    maxon

    Cirtec Medical

    Braxton Manufacturing

    LEMO USA Inc.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Telemedicine for Neurology: 5 Benefits of Remote Management

    Machining 101: A Review of Machining Components with a Five-Axis System

    MedTech 2024: Top 5 Trends Shaping a Dynamic Industry

    Early Warning: A Q&A with Abbott's CMO of Heart Failure

    2023 in Review: Medtech's Mega-M&A Is MIA
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Poly-Med, Inc.

    maxon

    Cirtec Medical

    Braxton Manufacturing

    LEMO USA Inc.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Online Exclusives

    An Overview of the ASCA Pilot Program

    The FDA published a three-part final guidance on the voluntary program.

    An Overview of the ASCA Pilot Program
    The ASCA Pilot program was set up to foster an accredited conformity assessment arrangement between medical device manufacturers, accreditation bodies, and testing laboratories. Image courtesy of MasterControl.
    David Jensen, Staff Writer, MasterControl03.11.21
    In September 2019, the U.S. Food and Drug Administration (FDA) Center for Device and Radiological Health (CDRH) introduced the Accreditation Scheme for Conformity Assessment (ASCA) Pilot. The program was set up to foster an accredited conformity assessment arrangement between medical device manufacturers, accreditation bodies, and testing laboratories. After receiving comments from the public and industry stakeholders, the FDA released its final guidance for the ASCA Pilot in September 2020.
     
    The Purpose of the ASCA Pilot
    In a nutshell, the FDA intends for the ASCA Pilot to use accredited, third-party testing laboratories to assess the declaration of conformity (DOC) provided by medical device manufacturers in their premarket submissions. These assessments will determine the company’s adherence to the agency’s consensus standards for safety, performance, and biocompatibility.
     
    The voluntary pilot program is designed to help make medical device and in vitro diagnostic (IVD) product premarket reviews more consistent and efficient. The agency also intends for the program to reduce the regulatory burden on device manufacturers by increasing product reviewers’ trust in medical device testing.
     
    ASCA Pilot Final Guidance
    The final guidance for the ASCA Pilot is considerably more comprehensive than the original draft. One notable variance is it includes an expanded section on the policies and processes involved in testing products. For example, guidelines regarding the organizational structure, environmental conditions, and resources of the testing laboratories include:
     
    • Ensuring staff is qualified and continually trained on methods to conduct testing within the scope of the regulations and standards.
    • Implementing procedures for governing the development, maintenance, and use of tests.
    • Maintaining testing equipment to ensure it remains in proper working order according to the accreditation requirements.
    • Setting up procedures for identifying testing errors caused by incorrect calibration or operation of equipment that could affect the accuracy and reliability of testing results.
    • Documenting and reporting all required information as detailed in ISO/IEC 17025.
     
    The FDA’s final guidance for the ASCA Pilot is dispersed across three guidance documents:
     
    • Goals and implementation of ASCA Pilot
    • Basic safety and essential performance standards
    • Biocompatibility testing of medical devices
     
    This article highlights aspects of each guidance that apply to medical device manufacturers and accredited testing laboratories participating in the ASCA Pilot.
     
    #1: ASCA Pilot – Goals and Implementation
    When the FDA first set up the ASCA Pilot in September 2019, the agency set goals for how the program will support its ongoing efforts to use its scientific resources effectively and efficiently to protect and promote public health.
     
    • Enhance confidence in medical device testing – Includes application processes and periodic audits of ASCA-recognized accreditation bodies to ensure they meet the criteria specified by the FDA.
    • Promote consistency and predictability in the premarket review process – The FDA’s commitment to clearly communicate expectations for how results from ASCA-accredited testing laboratories will be included and reviewed in premarket submissions.
    • Encourage effective use of FDA resources – Enlisting third-party organizations to participate in assessing the declaration of conformity (DOC) submissions from manufacturers allows the FDA to devote scientific and regulatory resources to other pertinent priorities.
    • Enhance regulatory efficiency – The FDA expects the application process, periodic audits, and clear communication among participants in the ASCA Pilot will decrease the need for additional information regarding testing methodologies, which will help speed up the submission process.
    • Support international harmonization – In developing the ASCA Pilot, the FDA used elements from international conformity assessment standards in the ISO/IEC 17000 series. In addition, most of the FDA-recognized consensus standards and test methods selected for the ASCA Pilot are international consensus standards.
     
    Medical device manufacturers can use testing performed by an ASCA-accredited testing laboratory to support their premarket submission as long as the laboratory uses an FDA-recognized consensus standard.
     
    #2: Basic Safety and Essential Performance Standards
    This segment of the guidance addresses the responsibilities of accredited laboratories in developing test plans and procedures. For example, tests should be project-specific and include documentation of test details the FDA has itemized in the guidance, such as:
     
    • Test identification information, including title, document number, revision, and effective date
    • Specific test equipment required
    • Warning/caution statements to alert operators of potential hazards
    • Normal and/or unusual ambient conditions, including tolerances for tests
    • Test data to be obtained and recorded
    • Objective acceptance criteria
     
    The guidance includes guidelines for inspecting the manufacturer’s risk management file to obtain objective evidence. Laboratories must also provide a list of all documents examined during the inspection.
     
    #3: Biocompatibility Testing of Medical Devices
    Finally, regulatory bodies are committed to the protection of patient safety. That said, biocompatibility, which involves screening new medical devices for the possibility of patients experiencing adverse reactions, is a pivotal component of the ASCA Pilot.
     
    To comply with the biocompatibility requirements, participant accredited bodies must conform to guidelines in the ISO/IEC 17025 standard, which explains how laboratories need to demonstrate that they operate competently and generate valid results.
     
    In addition, this segment of the guidance states that “all testing should be conducted considering the recommendations in the CDRH Biocompatibility policy as described in the FDA’s guidance ‘Use of International Standard ISO 10993-1.’” The agency created this guidance to assist medical device manufacturers with preparing premarket applications for devices that have direct or indirect contact with the human body. It advises manufacturers on using risk-based approaches to determine if biocompatibility is needed.
     
    Conclusion
    The ASCA Pilot is voluntary. Device manufacturers that choose to use an ASCA-accredited testing laboratory to conduct testing are responsible for including the appropriate information regarding device testing in their premarket submissions. The FDA is still building the ASCA Pilot. As with other pilot programs, the agency will determine at a future date if more regulations, legislation, and public input will be needed before transitioning the ASCA Pilot to a permanent program.


    David Jensen is a staff writer for MasterControl.
    Suggested For You
    WESTPAK Inc. WESTPAK Inc.
    DDL Inc. DDL Inc.
    Hangsterfer Hangsterfer's Laboratories
    sfm medical devices GmbH sfm medical devices GmbH
    Simbex Simbex
    WuXi AppTec Medical Device Testing WuXi AppTec Medical Device Testing
    Critical Software Solutions Critical Software Solutions
    IMA Automation North America IMA Automation North America
    Anjon Medical Technologies Anjon Medical Technologies
    Nissha Medical Technologies Nissha Medical Technologies
    JK Medirise-Disposable Medical Device Company JK Medirise-Disposable Medical Device Company
    RJG RJG
    Web Industries Inc. Web Industries Inc.
    Auriga Inc. Auriga Inc.
    BMP Medical - Delivering Custom Plastics Manufactured Solutions BMP Medical - Delivering Custom Plastics Manufactured Solutions

    Related Buyers Guide Companies

    • Packaging & Sterilization
      WESTPAK Inc.

      WESTPAK Inc.

      ...
      Tim Eells, WESTPAK, Inc. 11.22.23

    • DDL Inc.

      DDL Inc.

      DDL has been in medical device package, product and material testing industry for almost 20 years. We strive to offer the most effective business practices while employing a staff of technical experts.
      Chris Murphy, Marketing Manager 11.20.23

    • Hangsterfer's Laboratories

      ...
      Ed Jones, COO / CTO 11.03.23


    • sfm medical devices GmbH

      ...
      Albert Busch, Head of Marketing 10.17.23

    • Simbex

      ...
      Greg Lange, Chief Executive Officer 10.12.23

    Loading, Please Wait..

    Breaking News
    • MPO's Most-Read Stories This Week—Dec. 9
    • Babson Diagnostics’ BetterWay Achieves Regulatory Milestone
    • WhiteSwell Successfully Treats Acute Decompensated Heart Failure in Study
    • Everly Health Releases At-Home Collection Kidney Health Test
    • Kenco Adds Two to its Life Sciences Division Team
    View Breaking News >
    CURRENT ISSUE

    November 2023

    • MPO's 2023 Medical Device Industry Year in Review
    • The Beat Goes On in the Cardiovascular Device Market
    • Medical Manufacturers Gain Support from 3D Printing
    • The Intelligent Tools Medical Device Manufacturers Already Own
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Women in Nutraceuticals Hires Executive Director Rebecca Takemoto
    FDA Issues Interim Response to Nammex’s Mushroom Labeling Petition
    MSM Linked to Improvements in Knee Pain
    Coatings World

    Latest Breaking News From Coatings World

    Weekly Recap: PPG, PPG Asian Paints, AkzoNobel Top This Week’s Stories
    Orion S.A. Has Four Carbon Black Plants Awarded ISCC PLUS
    Peninsula Polymers Acquires New Distribution Center in Indiana
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MPO's Most-Read Stories This Week—Dec. 9
    Babson Diagnostics’ BetterWay Achieves Regulatory Milestone
    WhiteSwell Successfully Treats Acute Decompensated Heart Failure in Study
    Contract Pharma

    Latest Breaking News From Contract Pharma

    FDA Approves Bio-Thera's Biosimilar Referencing Roche’s Avastin
    Full-Life Technologies to Build GMP Radiopharmaceuticals Mfg. Facility
    Innovent Biologics, Synaffix Expand ADC Licensing Deal
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    COSRX’s Latest TikTok Campaign Accumulates 3.2B Views on TikTok
    Christian Louboutin Taps Morgane Martini as Global Makeup Artist
    Shiseido Forms New Venture Fund
    Happi

    Latest Breaking News From Happi

    Christian Louboutin Names Morgane Martini Global Makeup Artist
    Estée Lauder Lead Scientist Dr. Nadine Pernodet To Lecture At SCC Science Meeting
    Topical Testosterone Formulation for Chest Hair Growth
    Ink World

    Latest Breaking News From Ink World

    Weekly Recap: Siegwerk, DIC, and Müller Martini Top This Week’s Stories
    Orion S.A. Now Has Four Carbon Black Plants Awarded ISCC PLUS
    BASF Commits to Scope 3.1 Emissions Targets
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Analyzing the Russian label market, Carter boosts brands and more
    FLAG’s December Lunch & Learn to feature Omet
    UPM Raflatac releases neuromarketing study findings
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Ginni Strikes Deal to Sell Spinning, Knitting Operations
    Campen Machinery Announces Patent Pending Status for Airlaid Trays
    Veocel Partners with Beauty and Feminine Care Brands in Asia Pacific
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    ODT's Most-Read Stories This Week—Dec. 9
    Fujitsu, iSurgery Launch Bone Health Promotion Project in Japan
    Wenzel Spine Hires Dr. Robert Gordon as Executive Chairman
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Weekly Recap: Schreiner MediPharm, GIANCE and PragmatIC Top This Week’s Stories
    Intel CEO Pat Gelsinger to Cover AI During CES 2024 Keynote
    Ciena Invests in US Manufacturing with Flex

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login